Chordomas;Les chordomes

Annales de Pathologie

Volumn 27, Issue 1, 2007, Pages 6-15

  Riopel, Céline ^a   Michot, Chantal ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Chordoma; Notochordal cells benign tumor; Notochordal hamartoma; Notochordal rest

Indexed keywords

BENIGN TUMOR; BONE TUMOR; CANCER RADIOTHERAPY; CHORDOMA; CHROMOSOME ANALYSIS; CYTOMETRY; HAMARTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; NOTOCHORD; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; PRECANCER; PROGNOSIS; RARE DISEASE; REVIEW;

EID: 34250173440     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0242-6498(07)88679-2     Document Type: Article

References (53)

1. Fletcher CDM., Unni KK, Mertens F. World Health Organization Classification of Tumours, Pathology and Genetics of tumours of Soft Tissue and Bone, IARC Press Lyon 2002 ; 316-7.
2. Salisbury JR. Embryology and pathology of the human notochord. Ann Pathol 2001 ; 21 : 479-88.
3. Forest M. Chordoma, Orthopedic surgical pathology, Churchill Livingstone , 1998 ; 397-413.
4. Mirra JM. Bone Tumors Clinical, Radiologic and Patholgic Correlations. Ed Lea et Febinger ; Philadelphia London 1989 ; vol 1 : 648-74.
5. Sung MS, Lee GK, Kang HS, Kwon ST, Park JG, Suh JS et al. Sacrococcygeal chordoma: MR imaging in 30 patients. Skeletal Radiol 2005 ; 34 : 87-94.
6. Smolders D, Wang X, Drevelengas A, Vanhoenacker F, De Schepper AM. Value of MRI in the diagnosis of non-clival, non-sacral chordoma. Skeletal Radiol 2003 ; 32 : 343-50.
7. Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T et al. Carbon-11-methionine positron emission tomography imaging of chordoma. Skeletal Radiol 2004 ; 33 : 524-30.
8. Fourney DR., Gokaslan ZL. Current management of sacral chordoma. Neurosurg focus 2003 ; 15 : E9.
9. Ozdemir MH, Gurkan I, Yildiz Y, Yilmaz C, Saglik Y. Surgical treatment of malignant tumours of sacrum. Eur J Surg Oncol 1999 ; 25 : 44-9.
10. Zileli M, Hoscoskun C, Brastianos P, Sabah D. Surgical treatment of primary sacral tumors: complications associated with sacrectomy. Neurosurg Focus 2003 ; 15 : E9.
11. York JE., Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA et al. Sacral chordoma : 40-year experience at a major cancer center. Neurosurgery 1999 ; 44 : 74-9 ; discussion 79-80.
12. Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C et al. Results of carbon ion radiotherapy in 152 patients. Int J Oncol Biol Phys 2004 ; 58 : 631-40.
13. Imai R, Kamada T, Tsuji H, Yanagi T, Baba M, Miyamoto T et al. Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 2004 ; 10 : 5741-6.
14. Anis N, Chawki N, Antoine K. Use of radio-frequency ablation for the palliative treatment of sacral chordoma. Am J Neuroradiol 2004 ; 25 : 1589-91.
15. Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A et al. Imatinib mesylate in chordoma. Cancer 2004 ; 101 : 2086-97.
16. O'Hara BJ, Paetau A, Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 1998 ; 29 : 119-26.
17. Kilgore S, Prayson RA. Apoptotic and proliferative markers in chordomas: a study of 26 tumors. Ann Diagn Pathol 2002 ; 6 : 222-8.
18. Matsuno A, Sasaki T, Nagashima T, Matsuura R, Tanaka H, Hirakawa M et al. Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas. Human Pathol 1997 ; 28 : 714-9.
19. Naka T, Fukuda T, Chuman H, Iwamoto Y, Sugioka Y, Fukui M et al. Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Hum Pathol 1996 ; 27 : 381-8.
20. Pallini R, Maira G, Pierconti F, Falchetti ML., Alvino E, Cimino-Reale G et al. Chordoma of the skull base: predictors of tumor recurrence. J Neurosurg 2003 ; 98 : 812-22.
21. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Pronostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 2000 ; 88 : 2122-34.
22. Holton JL, Steel T, Luxsuwong M, Crockard HA, Revesz T. Skull base chordomas: correlation of tumour doubling time with age, mitosis and Ki67 proliferation index. Neuropathol Appl Neurobiol 2000 ; 26 : 497-503.
23. Naka T, Boltze C, Samii A, Herold C, Ostertag H, Iwamoto Y et al. Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability. Cancer 2003 ; 98 : 1934-41.
24. Sell M, Sampaolo S, Di Lorio G, Theallier A. Chordomas: a histological and immunohistochemical study of cases with and without recurrent tumors. Clin Neuropathol 2004 ; 23 : 277-85.
25. Wynford-Thomas D. P53 in tumour pathology: can we trust immunohistochemistry? J Pathol 199 ; 166 : 329-30.
26. Stefanou DG, Nonni AV, Agnantis NJ, Athanassiadou SE, Briassoulis E, Pavlidis N. P53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study. Anticancer Res 1998 ; 18 : 4673-81.
27. Hruban RH., Traganos F, Reuter VE, Huvos AG. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications. Am J Pathol 1990 ; 137 : 435-47.
28. Berven S, Zurakowski D, Mankin HJ, Gebhardt MC, Sprigfield DS, Hornicek FJ. Clinical outcome in chordoma: utility of flow cytometry in DNA determination. Spine 2002 ; 27 : 374-9.
29. Schoedel KE, Martinez AJ, Mahoney TM., Contis L, Becich MJ. Chordomas: pathological features; ploidy and silver nucleolar organizing region analysis. A study of 36 cases. Acta Neuropathol (Berl) 1995 ; 89 : 139-43.
30. Persons DL, Bridge JA., Neff JR. Cytogenetic analysis of two sacral chordomas. Cancer Genet Cytogenet 1991 ; 56 : 197-201.
31. Gibas Z, Miettinen M, Sandberg AA. Chromosomal abnormalities in two chordomas. Cancer Genet Cytogenet 1992 ; 58 : 169-73.
32. De Boer JM, Neff JR, Bridge JA. Cytogenetics of sacral chordoma. Cancer Genet Cytogenet 1992 ; 64 : 95-6.
33. Mertens F, Kreicbergs A, Rydholm A, Willen H, Carlen B, Mitelman F et al. Clonal chromosome aberrations in three sacral chordomas. Cancer Genet Cytogenet 1994 ; 73 : 147-51.
34. Bridge JA., Pickering D, Neff JR. Cytogenetic and molecular cytogenetic analysis of sacral chordoma. Cancer Genet Cytogenet 1994 ; 75 : 23-5.
35. Buonamici L, Roncaroli F, Fioravanti A, Losi L, Van Den Berghe H, Calbucci F et al. Cytogenetic investigation of chordomas of the skull. Cancer Genet Cytogenet 1999 ; 112 : 49-52.
36. Tallini G, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD et al. Correlation between clinicopatholical features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morpholgy (CHAMP) Collaborative Study Group. J Pathol 2002 ; 196 : 194-203.
37. Gil Z, Fliss DM, Voskoboinik N, Leider-Trejo L, Spektor S, Yaron Y et al. Cytogenetic analysis of three variants of clival chordoma. Cancer Genet Cytogenet 2004 ; 154 : 124-30.
38. Butler MG, Dahir GA, Hedges LK, Juliao SF, Sciadini MF, Schwartz HS. Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas. Cancer Genet Cytogenet 1995 ; 85 : 51-7.
39. Klingler L, Shooks J, Fiedler PN, Marney A, Butler MG, Schwartz HS. Microsatellite instability in sacral chordoma. J Surg Oncol 2000 ; 73 : 100-3.
40. Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, Schulte M et al. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, UCH 1. Genes Chromosomes Cancer 2001 ; 32 : 203-11.
41. Kuzniacka A, Mertens F, Strombeck B, Wiegant J, Mandahl N. Combined binary ratio labeling fluorescence in situ hybridization analysis of chordoma. Cancer Genet Cytogenet 2004 ; 151 : 178-81.
42. Brandal P, Bjerkehagen B, Danielsen H, Heim S. Chromosome 7 abnormalities are common in chordomas. Cancer Genet Cytogenet 2005 ; 160 : 15-21.
43. Dalpra L, Malgara R, Miozzo M, Riva P, Volonta M, Larizza L et al. First cytogenetic study of a recurrent familial chordoma of the clivus. Int J Cancer 1999 ; 81 : 24-30.
44. Miozzo M, Dalpra L, Riva P, Volonta M, Macciardi F, Pericotti S et al. A tumor suppressor locus in familial and sporadic chordoma maps to 1p36. Int J Cancer 2000 ; 87 : 68-72.
45. Riva P, Crosti F, Orzan F, Dalpra L, Mortini P, Parafioriti A et al. Mapping of candidate region for chordoma developement to 1p36.13 by LOH analysis. Int J Cancer 2003 ; 107 : 493-7.
46. Mirra JM, Brien EW. Giant notochordal hamartoma of intraosseous origin: a newly reported benign entity to be distinguished from chordoma. Report of two cases. Skeletal Radiol 2001 ; 30 : 698-709.
47. Darby AJ, Cassar-Pullicino VN, Mc Call IW, Jaffray DC. Vertebral intra-osseous chordoma or giant notochordal rest? Skeletal Radiol 1999 ; 28 : 342-6.
48. Chauvel A, Taillat F, Gille O, Rivel J, Vital JM, Bioulac-Sage et al. Giant vertebral notochordal rest: a new entity distinct from chordoma. Histopathology 2005 ; 47 : 646-9.
49. Kyriakos M, Totty WG, Lenke LG. Giant vertebral notochordal rest: a lesion distinct from chordoma: discussion of an evolving concept. Am J Surg Pathol 2003 ; 27 : 396-406.
50. Yamaguchi T, Yamato M, Saotome K. First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions. Skeletal Radiol 2002 ; 31 : 413-8.
51. Yamaguchi T, Suzuki S, Ishiiwa H, Ueda Y. Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas? Histopathology 2004 ; 44 : 597-602.
52. Yamaguchi T, Suzuki S, Ishiiwa H, Shimizu K, Ueda Y. Benign notochordal cell tumors: A comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs. Am J Surg Pathol 2004 ; 28 : 756-61.
53. Yamaguchi T. Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors. Mod Pathol 2005 ; 18 : 1005-10.